Jean-Frederic Viret
CIK 1427569 · Chief Financial Officer · last filed 2026-02-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$96.2K
Companies
4
Total Filings
43
Lifetime Open-Market Net
-$2.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGP | Chief Financial Officer | — | $18.44 | — | $0 | 1 | 2026-02-09 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Chief Financial Officer | 0 | $1.54 | $0 | $0 | 2 | 2024-04-08 |
| CHRS | Chief Financial Officer | 68,697 | $1.40 | $96.2K | -$2.85M | 36 | 2021-02-03 |
| ANESIVA, INC. (ANSV) Delisted | VP and Chief Financial Officer | 6,541 | — | — | $0 | 2 | 2008-12-05 |
Recent Filings · Page 5 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-03 | — | Grant (A) | — | $0 | |
| 2008-12-05 | ANESIVA, INC. (ANSV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-10-16 | ANESIVA, INC. (ANSV) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–43 of 43
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.